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Iron supplementation in pregnancy
At last, benefits on maternal measures and risk of low birth weight are shown
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In the linked review andmeta-analysis of anaemia, prenatal iron
use, and the risk of adverse pregnancy outcomes (doi:10.1136/
bmj.f3443), Haider and colleagues make a strong case for iron
supplementation in pregnancy.1 Iron deficiency is the world’s
most common and widespread nutritional disorder. Not only
does it affect manywomen and children in developing countries,
it is the one nutritional deficiency that is also highly prevalent
in industrialised countries. World Health Organization data
indicate that a staggering two billion people—around 30% of
the world’s population—may have anaemia, mainly as a result
of iron deficiency, often exacerbated in resource poor areas by
infectious disease.2 Iron deficiency is thus an important health
problem worldwide.
Pregnant women, and women of childbearing age in general,
are in particular need of iron supplementation. Even under
optimal dietary conditions, daily intestinal absorption cannot
meet the pregnancy requirement of 1-1.2 g iron.3 But curiously
the case for iron supplementation remained unconfirmed after
Cochrane reviews and other meta-analyses concluded that iron
supplementation preventedmaternal anaemia and iron deficiency
at term but was not beneficial (or harmful) in terms of neonatal
outcome (such as low birth weight, delayed development,
preterm birth, infection).4-6
Haider and colleagues comprehensively reviewed the evidence
from randomised trials and prospective cohort studies for an
association between anaemia, iron use in pregnancy, and
maternal and pregnancy outcomes. They concluded that daily
prenatal oral iron significantly reduced maternal anaemia, iron
deficiency, iron deficiency anaemia, and the risk of low birth
weight, but that the reduction in the risk of preterm birth was
not significant.1
Guidelines, prevention and treatment programmes, and expert
recommendations regarding the dose and route of daily iron
supplementation in pregnancy are conflicting.7 However, the
dose-response analysis by Haider and colleagues categorically
shows a linear decrease in maternal anaemia with increasing
iron doses up to 66mg per day, which approximates to theWHO
standard treatment of 60 mg per day.8 Increasing iron doses are
associated with linear increases in prenatal mean haemoglobin
and birth weight, hence with decreased risk of low birth weight.
The causes of preterm birth are complex andmultifactorial; they
include infection, inflammation, vascular disease, and stress.9
Finding a straight correlation between iron supplementation and
a reduction in preterm births was thus as unlikely in principle
as the philosopher’s stone. However, meta-analysis of the cohort
studies identified a higher risk of preterm birth in women with
anaemia in the first or second trimester and lower mean
haemoglobin. This finding adds to our understanding of the
complex causes of preterm birth andmodulates themultifactorial
approach needed for prevention.
Although not a primary focus of the analysis, the increase in
meanmaternal haemoglobin is likely to lower the risks of severe
postpartum anaemia and the need for transfusion in many young
and otherwise healthy women. This should equate indirectly to
a reduction in morbidity and mortality, whether perinatal and
neonatal or maternal, thanks to the simple measure of taking
one iron tablet a day during pregnancy.
The only flaw in Haider and colleagues’ study is that it has come
fractionally too late to claim the pride of place it deserves. After
long years of looking for better evidence favouring iron
supplementation in pregnancy, the Cochrane reviewwas updated
in December 2012.10 Its revised conclusions anticipated those
that Haider and colleagues have now masterfully and
comprehensively confirmed.
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